Today, the A-share market is led by high-standard pharmaceutical stocks on the decline list. Last week's leader, Qizheng Tibetan Medicine, hits the limit down and leads the decline. Pharmaceutical stocks are trending, with no stocks exceeding 3 consecutive limit ups. The leading trend stock, Angli Kang, is nearing the limit down. Lide Man stops at 3 consecutive limit ups, surging and then plummeting; Asia-Pacific Pharmaceuticals drops 8CM, while Xinguang Pharmaceuticals, Nanxin Pharmaceuticals, Guizhou Moutai, Chenxin Pharmaceuticals, and Shutaishen also experience significant declines.

The pharmaceutical sector leads the decline in the entire A-share industry, with high-standard pharmaceuticals leading the way, indicating that the market is recovering and rebounding, with funds cutting across high and low, experiencing supplementary declines at high positions and rotational increases at low positions.

Apart from pharmaceutical stocks, the biggest decline today was seen in Dongxin Co., which dropped 11CM. This stock has experienced significant volatility with large fluctuations between rising and falling; buying high is not advisable, only low buying is recommended. Additionally, the PCB leading trend stock, Honghe Technology, hits the limit down as a supplementary decline.

Today's decline list also features a 'Heaven and Earth' board, with Shengtong Energy directly hitting a limit down, resulting in a 'Heaven and Earth' board. Recently, high-standard stocks have frequently shown this pattern, accelerating to a limit and then suddenly hitting a 'Heaven and Earth' large decline. Therefore, short-term limit trading requires caution, and accelerated relay trading with reduced volume must be approached carefully; if the wrong relay is made, it will lead to a significant 'Heaven and Earth' decline.